This announcement in only one of several good news in HIV treatment progress. Janssen’s single-tablet regimen Symtuza has been approved last year by the European Commission for the treatment of ...

What challenges do regions such as Africa and Latin America face around access to HIV medicines? We have recently seen impressive results from the Purpose 1 and 2 studies, which evaluated the efficacy ...

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a ... Updated Hep B Vaccine More ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

NEW DELHI: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that demonstrated ... sold under the commercial name Sunlenca for the treatment ...

"Daily single-tablet regimens have helped to transform HIV care but can be challenging for some people to maintain," said Dr Elizabeth Rhee, head of Merck Research Laboratories. "Novel HIV ...

PrEP is medicine for people at risk of getting HIV through sex or injection-drug use; it has been shown to reduce the risk of HIV infection by up to 92 per cent. The drug is given free by the HSE ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Genotypic testing for HIV ...

Drugs that treat HIV and related infections can also trigger rashes. These often go away several days or weeks after you stop taking the drug. Talk with your doctor before stopping any medication.

Dolutegravir is an HIV integrase strand transfer inhibitor ... enzymes and therefore is associated with few drug interactions other than metformin and dofetilide. Dolutegravir should be ...

Initially filed in 2020, this lawsuit against the federal government argues that the ACA's mandated coverage of HIV pre-exposure ... homosexual behavior, drug use, and sexual activity outside ...